SpringWorks Therapeutics, Inc.
NASDAQ: SWTX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Saqib Islam
- Employees
- 368
- Headquarters
- Stamford, United States
- IPO year
- 2019
- Market cap
- $3.5B
- Website
- https://www.springworkstx.com
Loading SWTX…
Loading profile data…Frequently asked questions about SWTX
What does SpringWorks Therapeutics, Inc. (SWTX) do?
SpringWorks Therapeutics, Inc. is a biopharmaceutical company dedicated to identifying, developing, and commercializing innovative therapies for patient populations grappling with rare diseases and various forms of cancer, often those with significant unmet medical needs. The company's most advanced experimental treatment is nirogacestat, an ora...
Where does SWTX trade?
SpringWorks Therapeutics, Inc. (SWTX) trades on the NASDAQ Global Select.
What sector is SWTX in?
SpringWorks Therapeutics, Inc. (SWTX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of SpringWorks Therapeutics, Inc.?
Saqib Islam is the chief executive officer of SpringWorks Therapeutics, Inc. (SWTX).
Where is SpringWorks Therapeutics, Inc. headquartered?
SpringWorks Therapeutics, Inc. is headquartered in United States.
Does SWTX pay a dividend?
SpringWorks Therapeutics, Inc. (SWTX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SWTX go public?
SpringWorks Therapeutics, Inc. (SWTX) completed its initial public offering in 2019.